18:26:08 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-24 Kvartalsrapport 2024-Q3
2024-07-16 Kvartalsrapport 2024-Q2
2024-05-15 Ordinarie utdelning BACTI B 0.00 SEK
2024-05-14 Årsstämma 2024
2024-04-25 Kvartalsrapport 2024-Q1
2024-02-08 Bokslutskommuniké 2023
2023-10-27 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-05-08 Ordinarie utdelning BACTI B 0.00 SEK
2023-05-05 Årsstämma 2023
2023-04-27 Kvartalsrapport 2023-Q1
2023-02-09 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-07-14 Kvartalsrapport 2022-Q2
2022-05-02 Ordinarie utdelning BACTI B 0.00 SEK
2022-04-29 Årsstämma 2022
2022-04-27 Kvartalsrapport 2022-Q1
2022-02-10 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-04-29 Ordinarie utdelning BACTI B 0.00 SEK
2021-04-28 Årsstämma 2021
2021-04-22 Kvartalsrapport 2021-Q1
2021-02-04 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-13 Kvartalsrapport 2020-Q2
2020-05-13 Kvartalsrapport 2020-Q1
2020-04-29 Ordinarie utdelning BACTI B 0.00 SEK
2020-04-28 Årsstämma 2020
2020-02-05 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-08-08 Kvartalsrapport 2019-Q2
2019-05-16 Ordinarie utdelning BACTI B 0.00 SEK
2019-05-15 Årsstämma 2019
2019-05-09 Kvartalsrapport 2019-Q1
2019-02-07 Bokslutskommuniké 2018
2018-11-06 Kvartalsrapport 2018-Q3
2018-08-08 Kvartalsrapport 2018-Q2
2018-05-17 Ordinarie utdelning BACTI B 0.00 SEK
2018-05-16 Årsstämma 2018
2018-05-08 Kvartalsrapport 2018-Q1
2018-02-06 Bokslutskommuniké 2017
2017-11-09 Kvartalsrapport 2017-Q3
2017-08-10 Kvartalsrapport 2017-Q2
2017-05-19 Ordinarie utdelning BACTI B 0.00 SEK
2017-05-18 Årsstämma 2017
2017-05-04 Kvartalsrapport 2017-Q1
2017-02-09 Bokslutskommuniké 2016
2016-11-10 Kvartalsrapport 2016-Q3
2016-08-11 Kvartalsrapport 2016-Q2
2016-05-20 Ordinarie utdelning BACTI B 0.00 SEK
2016-05-19 Årsstämma 2016
2016-05-12 Kvartalsrapport 2016-Q1
2016-02-18 Bokslutskommuniké 2015
2015-11-12 Kvartalsrapport 2015-Q3
2015-08-13 Kvartalsrapport 2015-Q2
2015-05-22 Ordinarie utdelning BACTI B 0.00 SEK
2015-05-21 Årsstämma 2015
2015-05-12 Kvartalsrapport 2015-Q1
2015-02-19 Bokslutskommuniké 2014
2014-11-14 Analytiker möte 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Bactiguard är ett globalt medicinteknikbolag som förebygger vårdrelaterade infektioner orsakade av medicintekniska produkter. Teknologin baseras på ett ultratunt ädelmetallytskikt som förebygger mikrobiell adhesion och bildande av biofilm. Bactiguard verkar genom licenssamarbeten med MedTech-företag som tillämpar teknologin på sina medicintekniska produkter. Bolaget har även en portfölj med sårvårdsprodukter. Bactiguard har sitt huvudkontor i Stockholm.
2023-11-21 15:15:00

Bactiguard Holding AB (publ.) has appointed Patrick Bach as new CFO. Patrick comes most recently from Atos Medical where he had a variety of strategic leadership roles over a period of almost 10 years. He brings vast experience from the medtech industry and assumes the CFO position as of today. Patrick will be part of the Executive Management team at Bactiguard and report to the CEO.

Patrick Bach will, in addition to Group Finance, be responsible for Strategy and Digital at Bactiguard. Bactiguard's current CFO, Carin Jakobson, assumes a role as Finance Director and leaves the Executive Management team. She will report to CFO Patrick Bach.

"As Bactiguard has entered the largest strategic shift in its history, to transform into a knowledge-driven partnership company, we are adding resources to match both the challenges and opportunities that lie ahead. In Patrick, we get a combination of finance and vast experience from the medtech industry as well as strategic, growth and transformation competence. Patrick shares our values and will be a great contributor to the entire firm," says CEO Thomas von Koch.

"I am really looking forwad to joining Bactiguard, we are at a critical point where our infection prevention technology can make a huge impact to global healthcare issues, not the least antimicrobial resistance. The new license focused strategy is set to unleash Bactiguard's full potential and I can't wait to get to know the team and the business and chip in with full force to capture the exiciting opportunities that we have ahead of us," comments Patrick Bach, Bactiguard's new CFO.

Patrick Bach was born in 1983 and holds a BSc in Economics and Business Administration and MSc in Finance and Strategic Management, both from Copenhagen Business School. Before Atos Medical, he worked with Coloplast Wound Care as Head of Strategy.